New product Xtonic

An innovative Medical Device, patented, with European certification from Cermet.

Xtonic®, a combination of sodium chloride and D-mannitol, in an optimal ratio, has been specifically designed for the inhalator treatment of Cystic Fibrosis, Primary ciliary dyskinesia and Bronchiectasis.

The combination of two effective ingredients in an optimal dosage to achieve a better tolerability and efficacy compared to hypertonic saline or mannitol, alonextonic

Swiss Synergy Pharma is well-positioned to bring

cutting-edge solutions

TO THE MARKET

We are open for new partnerships

SYNERGY SWISS PHARMA

BUSINESS DEVELOPMENT

SYNERGY SWISS PHARMA

ENGINEERING

SYNERGY SWISS PHARMA

NICOTINE

Synergy Swiss Pharma Sagl

Via Luigi Lavizzari 4, 6850 Mendrisio - Switzerland
+41 (0) 91 980 91 62
+41 (0) 91 930 70 71
barbara@synergypharma.ch

NEW OPENING

MALAYSIA

WITH DISTRIBUTION IN WHOLE ASIA FOR API AND FDF